Related Experiment Video
Updated: May 15, 2026
09:04
DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
Neuropeptides in inflammatory bowel disease: an update
M Reinshagen1, B Egger, F Procaccino
1Department of Internal Medicine I, University of Ulm, Germany; and *Harbor-UCLA Medical Center, Division of Gastroenterology, Torrance, California, U.S.A.
Inflammatory Bowel Diseases
|January 4, 2013
Summary
Gut neurons release neuropeptides that regulate mucosal defense and repair. Imbalances in these neurochemical signals may drive inflammatory bowel disease (IBD) pathogenesis, offering potential therapeutic targets.
Area of Science:
- Gastroenterology
- Neuroimmunology
- Molecular Biology
Background:
- The gastrointestinal tract's nervous system utilizes neuropeptides to manage mucosal defense, inflammation, and repair.
- Neurovascular peptidergic systems play a dual role, initially protective but potentially pathogenic in chronic inflammation.
Purpose of the Study:
- To explore the role of neuropeptides in gut inflammation and inflammatory bowel disease (IBD).
- To analyze insights from animal models of experimental gut inflammation.
Main Methods:
- Review of studies on animal models of experimental gut inflammation.
- Analysis of neuropeptide synthesis, release, binding, and degradation during inflammation.
Main Results:
- Gut neurons release diverse neuropeptides that modulate mucosal immunity and tissue repair.
- Neurovascular peptidergic systems exhibit plasticity during inflammation, with altered peptide dynamics.
- A balance exists between pro-inflammatory (e.g., SP, VIP, NPY) and anti-inflammatory (e.g., CGRP, somatostatin) neuropeptides.
Conclusions:
- Disturbances in the neuropeptide balance may contribute to inflammatory bowel disease (IBD) pathophysiology.
- Understanding these neuro-immune interactions may reveal novel therapeutic strategies for IBD.
- Neurovascular regulation is a critical factor in gut inflammatory processes.
Related Concept Videos
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...